![](https://29ru.net/datas/images/favicons/20687.png)
Samsung Bioepis Gets FDA Approval for Biosimilar to AstraZeneca’s Soliris
The South Korean company’s Epysqli is now FDA-approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome in the U.S., having grabbed the lead in the Soliris biosimilar market in Europe.